Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07764146
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's DiseaseVoyager TherapeuticsNot Yet RecruitingPhase 1
NCT07764146Not Yet Recruiting
Phase 1
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheim...Voyager Therapeutics
NCT07762248
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular Permanent Molars With Necrotic Pulp and Apical PeriodontitisMohamed Ashraf AbdeenNot Yet RecruitingPhase 2
NCT07762248Not Yet Recruiting
Phase 2
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular...Mohamed Ashraf Abdeen
NCT07761936
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor FluctuationsUniversita di VeronaRecruitingPhase 3
NCT07761936Recruiting
Phase 3
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fl...Universita di Verona
NCT07762820
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder TumorsLudwig-Maximilians - University of MunichNot Yet RecruitingNot Applicable
NCT07762820Not Yet Recruiting
Not Applicable
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retr...Ludwig-Maximilians - Univ...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07762053
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomonitor TonometerEyeCBetter CorporationNot Yet RecruitingNot Applicable
NCT07762053Not Yet Recruiting
Not Applicable
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomon...EyeCBetter Corporation
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07764055
A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)Medprin Regenerative Medical Technologies Co., Ltd.CompletedPhase 3
NCT07764055Completed
Phase 3
A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)Medprin Regenerative Medi...
NCT07763041
Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, Maternal Attachment, and Infant Health in the NICUAnkara Medipol UniversityCompletedNot Applicable
NCT07763041Completed
Not Applicable
Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, M...Ankara Medipol University
NCT07762664
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patients With Carotid Artery StenosisChinese PLA General HospitalRecruiting
NCT07762664Recruiting
—
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patie...Chinese PLA General Hospi...
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07762404
Reconstruction of First Web Space After Trauma and BurnSohag UniversityNot Yet RecruitingNot Applicable
NCT07762404Not Yet Recruiting
Not Applicable
Reconstruction of First Web Space After Trauma and BurnSohag University
NCT07762768
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With PrediabetesCSIR National Institute for Interdisciplinary Science and Technology (NIIST), ThiruvananthapuramNot Yet RecruitingNot Applicable
NCT07762768Not Yet Recruiting
Not Applicable
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Res...CSIR National Institute f...
NCT07762092
A Post Authorization Registry Study of Participants Treated With LEQEMBIEisai LimitedNot Yet Recruiting
NCT07762092Not Yet Recruiting
—
A Post Authorization Registry Study of Participants Treated With LEQEMBIEisai Limited
NCT07763392
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the LifespanIntraneuronRecruiting
NCT07763392Recruiting
—
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digit...Intraneuron
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07763405
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hospital of Nanchang UniversityNot Yet RecruitingPhase 4
NCT07763405Not Yet Recruiting
Phase 4
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hosp...
NCT07762027
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionAssembly BiosciencesNot Yet RecruitingPhase 2
NCT07762027Not Yet Recruiting
Phase 2
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Part...Assembly Biosciences
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
Result Breakdown
Not yet recruiting13 (65%)
Recruiting5 (25%)
Completed2 (10%)
not_applicable6 (30%)
Not Specified5 (25%)
Phase 34 (20%)
Phase 23 (15%)
Phase 11 (5%)
Phase 41 (5%)